“Beyond Weight Loss: Practical Considerations for Use of Glucagon Like Peptide-1 (GLP-1) and Incretin Therapy in Inflammatory Skin Disease”. Canadian Dermatology Today 7, no. 3 (September 25, 2026): 11–16. Accessed September 28, 2026. https://canadiandermatologytoday.com/article/view/7-3-Shi_et_al.